Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-Q
Source: 0001640334-25-001302
Chunk: 1

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-Q
Item: Item 1
Chunk 1
---
 expense        Interest expense - related parties  1,367   954 Total other expenses  1,367   954          Loss before income tax expense  (10,301)  (11,252)Income tax expense  -   - Net loss $(10,301) $(11,252)         Basic and diluted Loss per share of common stock $(0.00) $(0.00)         Weighted average number of shares of common stock outstanding  60,042,000   60,042,000 

The accompanying notes are an integral part of these unaudited financial statements.

 5Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Changes in Stockholders’ Deficit

(Unaudited)

For the Three months ended March 31, 2025

              Additional     Total   Preferred Stock  Common Stock   Paid in   Accumulated   Stockholders’    Shares    Amount    Shares    Amount    Capital    Deficit   Deficit                       Balance, December 31, 2024  -  $-   60,042,000  $60,042  $32,302,781  $(32,657,795) $(294,972)                             Imputed interest on related party loans  -   -   -   -   1,367   -   1,367 Net loss  -   -   -   -   -   (10,301)  (10,301)                             Balance, March 31, 2025  -  $-   60,042,000  $60,042  $32,304,148  $(32,668,096) $(303,906)

For the Three months ended March 31, 2024

              Additional     Total    Preferred Stock  Common Stock   Paid in   Accumulated   Stockholders’    Shares    Amount    Shares    Amount    Capital    Deficit   Deficit                       Balance, December 31, 2023  -